Skip to content

PTSD: Is There Any Relief?

PTSD: Is There Any Relief?

In honor of PTSD awareness month, let’s take a look at the debilitating mental health condition and how medical marijuana could help.Post-traumatic stress disorder is a mental health condition caused by witnessing or experiencing a traumatic event. It is understandable for one to be taken aback and impacted by a traumatic event, but if specific symptoms tend to stick around and affect a patient’s day-to-day life, it is important to consider PTSD as a cause.

Core Symptoms

  • Re-experiencing the event through intrusive flashbacks and nightmares
  • Avoidance of places, people and activities that are reminders of the traumatic event
  • Emotional numbness
  • Feeling jumpy, irritable or angry

Current Treatments

The treatment of PTSD often involves a combination of psychotherapy and medications. Cognitive behavioral therapy (CBT) has been found to be particularly helpful for treating PTSD. While treating PTSD with psychotherapies like CBT and medications can show some results for specific symptoms, many have started to search for a better alternative. With increasing data and efficacy reports circulating, medical marijuana is stepping into the spotlight as a better solution to easing symptoms.

How Can Medical Marijuana Help?

Cannabinoids found in cannabis activate the two main cannabinoid receptors in the endocannabinoid system (CB1 and CB2), which in turn produces a wide range of impacts on the central nervous system. These effects dramatically help PTSD patients manage the main symptoms of their condition, which include re-experiencing, avoidance and numbness, and hyperarousal.    

Reduce anxiety:

Studies have shown that people suffering from PTSD have much lower levels of a neurotransmitter called anandamide, which stimulates the mood and operates as a natural antidepressant. Using medical cannabis jumpstarts the body’s endocannabinoid system where it is lacking, which reduces the anxiety and irritability experienced from PTSD.

Reduce insomnia and nightmares:

Cannabis can also help prevent nightmares by reducing the REM sleep. By doing so, the vivid dreams that occur during this stage subside allowing cannabis to relieve any recurring nightmares that are associated with the patient’s PTSD.

In fact, a study was conducted to test this hypothesis by utilizing a cannabinoid receptor stimulant called nabilone. This involved 47 patients who despite using antidepressants and seeing a psychiatrist regularly, continued to have recurring nightmares. Following treatment, 72% of patients stopped having nightmares or had their severity drastically reduced. (Health Care in America)

Along with reducing the number of terrifying nightmares with medical cannabis, patients also reported that the quality and duration of sleep improved, while daytime flashbacks and night sweats decreased. Findings like these are major developments in the potential proof that medical cannabis could serve as a much more effective role in conditions like PTSD.

Are you interested in exploring medical marijuana treatments for your patients? Join Arfinn Med for FREE to access peer-to-peer data on medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings

Sources:

https://www.mayoclinic.org/diseases-conditions/post-traumatic-stress-disorder/symptoms-causes/syc-20355967
https://healthcareinamerica.us/cannabis-key-treating-ptsd-b4abf432215
https://adaa.org/understanding-anxiety/posttraumatic-stress-disorder-ptsd/symptoms
https://parkridgehealth.com/blog/entry/post-traumatic-stress-disorder-ptsd-what-you-need-to-know

Stories you may be interested in

New Feature: Calendar Integration

At Arfinn Med, we’re excited to announce the third feature update to join automated text messaging and note templating: calendar integration. With this addition, physicians can now integrate their Google Calendar or Calendy account. The implementation of calendar integration rounds out the Arfinn Med portal, making it a physician’s one-stop-shop EMR tool. How It Works…
Read More

Alternative Mississippi medical marijuana program barely wins approval from Senate

JACKSON • Legislation that would create a new medical marijuana program in Mississippi if the voter-approved Initiative 65 is overturned in court cleared the state Senate on the second try last week early on Friday morning. Senate Bill 2765, the Mississippi Medical Cannabis Act, failed by a single vote Thursday evening. But six hours later, after…
Read More

Cannabis reduces blood pressure in older adults, according to Ben-Gurion University researchers

Beer-Sheva, Israel…February 8, 2021 – A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults. The study, published in the European Journal of Internal Medicine, is the first of its kind to focus on the effect…
Read More

CEO Spotlight: James West

As a former academic coordinator for the City University of New York Research Foundation and Medgar Evers College, CEO and co-founder of Arfinn Med, James West, has extensive experience in adult education and professional training programming. James put this extensive education to good use when he noticed that there was a direct need for a…
Read More

PTSD and Cannabis

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that occurs in people who witnessed or have gone through a traumatic event.  That can include events such as  natural disasters, war/combat, a serious accident, or personal assault, among others.  People suffering from PTSD have disturbing thoughts and feelings related to the traumatic event that can last…
Read More

Survey of oncologists finds knowledge gap on medical marijuana

As more states legalize medical marijuana, two key groups — researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users — are struggling to catch up with policymakers. Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial…
Read More

Leave a Comment

You must be logged in to post a comment.